Christopher Blosser, United States
Clinical Considerations for Initiating Immune Checkpoint Inhibitors in Cutaneous Malignancy Treatment Post-transplantation

Naoka Murakami, United States
Challenges in Managing Cutaneous Malignancy Post-transplant: Adjusting Maintenance Immunosuppression Strategies

Germaine Wong, Australia
Evaluating Recurrence Risk of Cutaneous Malignancies in Transplant Recipients: Implications for Candidacy Assessment

Sarah Arron, United States
Risk of Cutaneous Malignancies in Transplant Recipients: Implications for Listing and Screening